Outcome of Anderson Hynes Dismembered Pyeloplasty in Paediatric Pelvic Ureteric Junction Obstruction
Keywords:
Anderson Hyne’s dismembered pyeloplasty, Clavien Dindo, Pelvic ureteric junction obstructionAbstract
Background
Anderson Hynes dismembered pyeloplasty is the gold standard procedure for management of Pelvic Ureteric Junction Obstruction (PUJO) in children with success rate of 90-95%. The aim of the current study is to evaluate safety, efficacy and outcomes of Anderson Hynes Pyeloplasty in our part of the world.
Method
A retrospective study was conducted involving 69 children who underwent Open Anderson Hyne’S dismembered Pyeoplasty over a period of 2 years from March 2022 to April 2024. Patient were evaluated with respect to age, sex, ultrasonographic grading of hydronephrosis, affected side, operation time, postoperative complications and follow-up outcomes and analyzed.
Result
This study consisted of 69 patients with moderate to severe hydronpehrosis secondary to PUJO underwent open pyeloplasty. Male-female ratio was 2:1. Average mean age was 41.67 months (1 month to 156 months) where 28 patients (40.57%) were infants. 45 patients (65.2%) had grade 3 hydronephrosis whereas 24 patients (34.8%) had grade 4 hydronephrosis in ultrasound abdomen.
Right sided pyeloplasty was performed in 48 children (69.6%) and left sided was performed in 21 children (30.4%). Mean operative time period was 92.5 minutes with mean hospital stay of 3.53 days (3 days to 5 days). Post-pyeloplasty, 63 patients (91.3%) showed improvement in ipsilateral kidney function on DTPA scan and three patient developed anastomotic stricture which required
Re-do Pyeloplasty.
Conclusion
Anderson Hyne’s dismembered pyeloplasty has shown better outcome amongst pediatric patient with PUJO. It has a high success rate with significant improvement in kidney drainage function.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
This license enables re-users to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.